AORT: Artivion, Inc. Forward P/E Multiple

Graphic logo of artivion.com (AORT)

High barriers to entry in the cardiovascular bioprostheses niche ensure stable growth for Artivion, Inc. (AORT). The company's forward P/E ratio confirms this trend, with the 130.00 mark serving as a key metric. Development relies on partnerships with clinics to create new implants and a streamlined delivery system for cryopreserved materials, which minimizes logistical risks.

artivion.com - AORT Price to Expected Earnings Ratio (period 07/04/2022 - 11/18/2026)

Artivion (AORT) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental valuation:AORT Artivion Corp
Brand item of artivion.com

Due to unique certification and a lack of low-cost alternatives in cardiac surgery, Artivion, Inc. (AORT) is shielded from price wars, which makes profit forecasts more stable. The ratio of the current share price to expected annual earnings allows for an assessment of whether the market value is fair relative to future cash flows. Analyzing the company's forward P/E ratio helps determine if an investor is overpaying for the issuer's leadership in the prosthetics niche.

Competitors of Artivion, Inc.

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings ENOV (Enovis)|IART (Integra LifeSciences Corp) - Future Price to Earnings Multiple|Future Price to Earnings Establishment Labs Inc ESTA|BBNX - Projected Price to Earnings|IRADIMED Corp - Forward P/E Multiple|Projected Price to Earnings Ratio Embecta Corp.|TNDM: Forward P/E Multiple|Price to Future Earnings Ratio AXGN|SIBN (SI-BONE Medical) - Forward P/E Multiple|Orthofix International (OFIX) - Market Cap to Projected Earnings|Forward P/E Multiple BVS|Projected Price to Earnings OrthoPediatrics KIDS|Forward P/E Multiple TMCI (treace.com)|Forward P/E Multiple Blade Air Mobility SRTA|CARL - Future Price to Earnings|RXST: Future Price to Earnings|CLPT (ClearPoint) - Projected Price to Earnings|Stereotaxis, Inc. - Future Price to Earnings Multiple|STIM (Neuronetics, Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Sight Sciences Inc. SGHT|Future Price to Earnings orchestrabiomed.com (OBIO)|Anika (ANIK) - Forward Price to Earnings Multiple|InspireMD Inc. - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd ZJYL|Vivani Medical Inc - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Med)|MYO (Myomo Inc.) - Forward P/E Multiple|Projected Price to Earnings Envoy Medical, Inc. (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO